Weeksella virosa is an aerobic Gram-negative rod that has rarely been reported to cause infection. We describe a fatal case of W. virosa sepsis in a young female with end-stage renal disease, report three additional cases of W. virosa infection, and review the literature regarding this infection.
described 78 strains of this organism, at the time called flavobacterium species IIf, isolated most commonly from urine (43%), cervical (14%), and vaginal (16%) specimens (14) , but also including 2 specimens each from blood and spinal fluid. Later, Holmes et al. suggested the current genus and species name, Weeksella virosa, and isolated the organism from the genital tract (34.4%), urine (37.9%), and other sites (17.2%), including blood, the umbilical area, the rectal area, ears, eyes, mastoid, and cerebrospinal fluid (5). Mardy et al. reported isolation from high vaginal swabs of the female genital tract at an incidence of 2% (2/100) from both asymptomatic healthy females and a group of females with symptoms of vaginal infections (7) . Interestingly, a third group from a British detention center, felt to be at high risk for sexually transmitted diseases, had an incidence of 15% (15/100). Also, Reina et al. described 3 strains of W. virosa identified from the analysis of female genital samples sent to their laboratory over a 12-month period (3/707 [0.42%]) (12) .
W. virosa appears as a Gram-negative rod on Gram stain. The organism will grow on blood and chocolate agar after 48 h of incubation at 22°C, 35°C, and 42°C. This organism does not grow on MacConkey agar, which is a distinguishing characteristic. Culture will produce cream-colored, mucoid colonies that may have a yellow tinge secondary to a nondiffusible pigment. The organism is oxidase positive, indole positive, and catalase positive (5, 14) . Care must be taken not to confuse Weeksella virosa with Bergeyella zoohelcum, an organism that has been associated with infections from animal bites (9) . Both are similar in most respects, but they can be differentiated based on the fact that B. zoohelcum is urease positive and polymyxin resistant.
There are no species-specific testing standards for this organism; however, the CLSI susceptibility testing interpretive standards table for "other non-Enterobacteriaceae" Gram-negative rods can be used (1a) . Studies of in vitro susceptibilities report that the following antimicrobials have activity against this organism: piperacillin, monobactams, cephalosporins, fluoroquinolones, and carbapenems. Resistance has been noted in vitro with aminoglycosides, nalidixic acid, and nitrofurantoin (3, 4, 7, 13) . There are varied results in the literature regarding the organism's sensitivity to tetracycline and trimethoprim-sulfamethoxazole (3, 4) .
We report a patient with W. virosa bacteremia and suspected pneumonia who presented with overwhelming sepsis. Despite the administration of appropriate empirical antibiotics, the patient expired 2 days after admission. The patient's severe course was likely exacerbated by ischemic cardiomyopathy complicated by acute on chronic systolic heart failure. A review of our microbiology cultures from 2003 to the present revealed an additional 3 cases of W. virosa infection (Table 1) . Additionally, there are four case reports in the literature describing W. virosa infections (Table 1) .
A review of these 8 cases revealed the following comorbidities: female (6/7), end-stage renal disease (3/8), obesity (3/8), liver disease (2/8), and diabetes mellitus (2/8). Of the 6 cases in which antimicrobial use was reported, aztreonam, ampicillin, imipenem/cilastin, trimethoprim-sulfamethoxazole, cefoxitin, and cefepime were used. Success was reported in 4 of 6 patients. In addition, one patient was successfully treated for a labial abscess with incision and drainage alone, and one patient's treatment history was not reported. From these patients' isolates, the following antimicrobial resistance rates were noted: amikacin, 5/5; gentamicin, 5/7; tobramycin, 5/5; ciprofloxacin, 4/7; trimethoprim-sulfamethoxazole, 2/2; and ceftazidime, 2/6. All of the organisms tested were sensitive to aztreonam (4/4), meropenem (4/4), and piperacillin (4/4).
W. virosa is a rare pathogenic bacterium that has been associated with pneumonia, bacteremia, peritonitis, and urinary tract infections. This organism appears to be more prevalent in females and in patients with comorbidities, such as renal disease, obesity, liver disease, and diabetes mellitus. It is important to consider this organism if your laboratory isolates an aerobic Gram-negative rod that grows after 36 to 48 h of incubation from either blood, sputum, urine, or peritoneal fluid. Piperacillin, aztreonam, and the carbapenems have reliable activity against this organism and should be used empirically once the organism is identified. Trimethoprim-sulfamethoxazole, ciprofloxacin, and the aminoglycosides should not be used unless antibiotic susceptibility results are available. More information is needed on the clinical presentation, diagnosis, and treatment of this uncommon organism. 
